Tirzepatide for Weight Loss in Jupiter, FL

What is tirzepatide?

Medically reviewed by Timothy W. Mackey, D.O., Medical Director, NovaGenix. Last reviewed: August 31, 2026.

The quest to combat obesity has long been an uphill battle, with health complications and mortality rates rising globally. A groundbreaking study, the SURMOUNT-1 trial, delved into uncharted territory, exploring the effectiveness and safety of tirzepatide, a novel treatment, in individuals grappling with obesity.

Mounjaro's main ingredient, Tirzepatide and its role in losing weight

Tirzepatide may be better known by most people as its brand name, Mounjaro. Originally developed to treat diabetes, it has gained fame as of late for its ability to help shed pounds. Recently, the U.S. Food and Drug Administration granted approval for obesity treatment to a drug known as Zepbound. This medication contains the active ingredient tirzepatide. Originally marketed as Mounjaro for diabetes management by EliLilly and Co., it's now authorized under the name Zepbound for weight management.

This approval extends its use to assist individuals dealing with obesity or overweight conditions, particularly those with related health issues such as high blood pressure or other similar chronic conditions. ABCNews reported that last month, a study was conducted and showed that tirzepatide helped some patients who were overweight or obese lose about a quarter of their body weight. When coupled with diet and exercise the results were more dramatic. The results also suggested that it could be more effective than Semaglutide.

Why obesity is difficult to treat

Obesity is a metabolic condition, not a willpower problem

Obesity's grasp extends far beyond physical weight; its repercussions stretch into various health domains, from cardiovascular diseases to type 2 diabetes. Traditional approaches focused on lifestyle modifications, but the complexity of obesity revealed a deeper, multifaceted metabolic condition, urging a shift in treatment strategies.

How does tirzepatide work?

Enter tirzepatide - a once-weekly injectable peptide developed from the native GIP sequence, armed with the ability to stimulate both GIP and GLP-1 receptors. This dual action aimed to address energy balance by tapping into multiple endogenous nutrient-stimulated hormonal pathways. Tirzepatide is a medication that belongs to a class of drugs known as incretin mimetics. It's a novel, once-weekly injectable drug that works as a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. Its mechanism of action involves several key aspects:

• GLP-1 Receptor Agonism: Tirzepatide activates the GLP-1 receptor, a hormone that stimulates the release of insulin from the pancreas in response to elevated blood sugar levels. This process helps to regulate blood sugar levels after meals.
• GIP Receptor Agonism: GIP is another hormone involved in the regulation of insulin release in response to food intake. Tirzepatide also acts on GIP receptors, further enhancing insulin secretion and reducing blood sugar levels.
• Appetite Regulation: GLP-1 agonists have been associated with reducing appetite and promoting a feeling of fullness, leading to decreased food intake. This effect can contribute to weight loss in individuals with obesity. The combined action on both GLP-1 and GIP receptors allows tirzepatide to address both blood sugar regulation and weight management in people with type 2 diabetes and obesity. By enhancing insulin release and reducing appetite, tirzepatide can help lower blood sugar levels, promoteweight loss, and improve various metabolic parameters. Its effectiveness in reducing body weight and improving metabolic outcomes has been demonstrated in clinical trials, making tirzepatide a promising medication for managing both diabetes and obesity.

The SURMOUNT-1 Trial: A Deep Dive Into Tirzepatide for Weight-Loss

How the SURMOUNT-1 trial was designed

In this phase 3 double-blind, randomized trial, published in The New England Journal of Medicine, 2539 adults with obesity, or those with weight-related complications, were enrolled. The participants were assigned to receive tirzepatide at varying doses or a placebo for 72 weeks.

What the SURMOUNT-1 trial found

The findings were groundbreaking: participants receiving tirzepatide showcased substantial weight reductions compared to the placebo group. The percentages were staggering: 85% to 91% of individuals on tirzepatide achieved weight reduction of 5% or more, a threshold known for its positive metabolic impacts. Moreover, higher weight-loss targets of 10% or more, 15% or more, and even 20% or more were achieved by a majority of participants across the tirzepatide groups.

Health improvements beyond weight loss

Tirzepatide not only helped shed pounds but also exhibited positive effects on various cardiometabolic risk factors. Improved waist circumference, blood pressure, insulin levels, and lipid profiles were notable among those on tirzepatide, potentially reducing the risk of cardiovascular diseases and type2 diabetes.

Some of the associated benefits discovered during clinical trials included:

1.Weight Loss: One of the most significant benefits of tirzepatide is its ability to induce substantial weight loss. Clinical trials have demonstrated remarkable reductions in body weight in individuals with obesity. It's been observed to be more effective than some other medications used for weight management. Recently, Wegovy has become a popular weight loss medication and its suggested that trizepatide may be even more effective.

2.Improved Glycemic Control: Tirzepatide has shown efficacy in reducing blood sugar levels in individuals with type 2 diabetes. It helps in controlling glucose levels by stimulating the release of insulin and suppressing glucagon, a hormone that raises blood sugar levels.

3. Metabolic Health Improvements: Apart from weight loss and glycemic control, tirzepatide has been associated with improvements in other metabolic parameters, such as reduced waist circumference, improved blood pressure, lipid levels, and increased insulin sensitivity.

4.Reduction in Cardiovascular Risk Factors: Clinical data suggests that tirzepatide may contribute to reducing the risk factors associated with cardiovascular diseases, including hypertension and dyslipidemia.

5. Potential Prevention of Diabetes Development: In individuals with prediabetes, tirzepatide has shown the ability to prevent the progression to type 2 diabetes. It promotes a shift from prediabetes to normoglycemia. These benefits can significantly impact the overall health and well-being of individuals with obesity and/or type 2 diabetes, potentially reducing the risk of associated complications and improving overall quality of life. However, it's important to consider these benefits in the context of individual health conditions and consult a healthcare professional to determine if tirzepatide is an appropriate treatment option.

What are the side effects of tirzepatide?

Safety was paramount, and tirzepatide showed a profile consistent with previous trials. Gastrointestinal events were the most commonly reported adverse events, primarily during the initial phase.

1.  Gastrointestinal Issues: Nausea, vomiting, diarrhea, and constipation are among the most common side effects reported. These symptoms often occur at the beginning of treatment or during dose escalation and may diminish over time.

2.  Hypoglycemia: Since tirzepatide worksto lower blood sugar levels, there's a risk of hypoglycemia (low blood sugar). This risk is higher when combined with other medications that lower blood sugar or in individuals with poor food intake.

3.  Injection-Site Reactions: Redness, itching, or pain at the injection site may occur.

4.  Decreased Appetite: Some people may experience a reduced appetite or a feeling of fullness, which can lead to decreased food intake.

5.  Potential Gallbladder-related Issues:Rarely, there have been reports of cholecystitis (inflammation of the gallbladder) or cholelithiasis (gallstones). These events are more commonly observed in individuals undergoing substantial weight loss, which is a potential side effect of this medication.

6.  Allergic Reactions: Although uncommon,allergic reactions such as rash, itching, or swelling might occur. Severe allergic reactions are rare but possible. It's important to note that the side effects experienced can vary from person to person. Some individuals may not experience any side effects, while others might have a few or several. If you're considering tirzepatide or any new medication, it's crucial to discuss potential side effects and risks with your healthcare provider. They can provide personalized guidance based on your health history and help manage any side effects that may arise during treatment.

Where tirzepatide fits in obesity treatment

The implications of these findings are profound. Tirzepatide demonstrated unprecedented weight reduction, rivaling even some surgical interventions. Moreover, it showcased potential benefits in improving overall body composition, presenting a promising tool in the medical management of obesity.

Who should not use tirzepatide or semaglutide?

Semaglutide and tirzepatide are not appropriate for everyone. These medications are contraindicated in patients with a personal or family history of medullary thyroid carcinoma (MTC), Multiple Endocrine Neoplasia syndrome type 2 (MEN 2), or a known serious hypersensitivity to the medication or its ingredients.

These medications also carry important warnings and precautions. Before treatment, patients should tell their healthcare provider about any history of pancreatitis, gallbladder disease, kidney problems, severe gastrointestinal disease or gastroparesis, diabetes or diabetic retinopathy, or previous serious reactions to GLP-1–based medications. Patients taking insulin or certain other diabetes medications may have an increased risk of hypoglycemia.

Semaglutide and tirzepatide used for weight management should be discontinued if pregnancy occurs. Patients who are pregnant, planning pregnancy, or breastfeeding should discuss this with their healthcare provider before treatment.

A medical evaluation and review of medications and health history are necessary to determine whether treatment is appropriate for an individual patient.

How Much Does Tirzepatide Cost?

NovaGenix is a self-pay practice and does not bill insurance. In practice that removes the parts of this process patients find worst: there is no prior authorization to chase, no insurance denial to appeal and no pharmacy back-and-forth. It also means the cost of treatment is paid directly.

There is no single program price, because patients need different medications, formulations, strengths, laboratory testing and follow-up. What you pay depends on what Dr. Mackey actually recommends for you after your evaluation.

Your expected cost is explained in full before you begin treatment, so you can decide whether to proceed. Call or text 561-277-8260 to ask about pricing for your situation.

How do I get tirzepatide at NovaGenix?

You start with a consultation at our Jupiter office, or by telehealth if you are an eligible patient in Florida. Call or text 561-277-8260 to schedule. NovaGenix does not prescribe tirzepatide on the basis of an online form.

Here is what the process looks like:

1. Schedule your consultation. Call or text NovaGenix at 561-277-8260. The team will explain what to bring and book your appointment.

2. Evaluation with Dr. Mackey. Every patient is seen by Timothy W. Mackey, D.O. — not a nurse practitioner or physician assistant. He reviews your medical history, your current medications and any existing health conditions.

3. Laboratory testing when it is needed. Labs are decided case by case rather than ordered automatically. They are most useful when an underlying cause such as a thyroid or hormone disorder may be contributing to your weight, and Dr. Mackey will tell you whether testing is warranted in your case.

4. Your treatment plan. If tirzepatide is appropriate, Dr. Mackey discusses dosing, what results to expect, side effects and what monitoring will involve. NovaGenix prescribes compounded tirzepatide, which is prepared by a licensed compounding pharmacy and is not an FDA-approved product.

5. Ongoing monitoring. Regular follow-up to track your progress, adjust dosing where appropriate and manage side effects, including protecting lean muscle during weight loss.

Start with a consultation in Jupiter

The SURMOUNT-1 trial heralds a new era in combating obesity, offering hope to millions worldwide. While the trial highlighted remarkable outcomes, further studies will unravel tirzepatide's full potential and its role in transforming obesity management. Losing weight brings a spectrum of health advantages that go beyond just shedding pounds. Beyond the obvious aesthetic changes, weight loss can significantly improve overall health.

It reduces the risk of chronic diseases like heart disease, type 2 diabetes, and hypertension. It enhances mobility, reducing joint pain and improving physical endurance. Weight loss also boosts mental health, fostering confidence and reducing stress. Moreover, it often leads to better sleep patterns and increased energy levels. Embracing a healthier weight isn't just about appearance; it's a gateway to a more vibrant, energetic, and fulfilling life.

Every patient at NovaGenix is seen by Timothy W. Mackey, D.O. Call or text 561-277-8260 to schedule a consultation in Jupiter, or to ask whether tirzepatide is an option for you.